CY1490A - Improvements in or relating to nasal pharmaceutical compositions - Google Patents

Improvements in or relating to nasal pharmaceutical compositions

Info

Publication number
CY1490A
CY1490A CY149083A CY149083A CY1490A CY 1490 A CY1490 A CY 1490A CY 149083 A CY149083 A CY 149083A CY 149083 A CY149083 A CY 149083A CY 1490 A CY1490 A CY 1490A
Authority
CY
Cyprus
Prior art keywords
relating
pharmaceutical compositions
nasal pharmaceutical
nasal
compositions
Prior art date
Application number
CY149083A
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of CY1490A publication Critical patent/CY1490A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CY149083A 1982-02-01 1983-01-28 Improvements in or relating to nasal pharmaceutical compositions CY1490A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8202781 1982-02-01
GB08302374A GB2114001B (en) 1982-02-01 1983-01-28 Nasel pharmaceutical compositions

Publications (1)

Publication Number Publication Date
CY1490A true CY1490A (en) 1990-02-16

Family

ID=26281857

Family Applications (1)

Application Number Title Priority Date Filing Date
CY149083A CY1490A (en) 1982-02-01 1983-01-28 Improvements in or relating to nasal pharmaceutical compositions

Country Status (2)

Country Link
CY (1) CY1490A (en)
GB (1) GB2114001B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT396870B (en) * 1986-08-07 1993-12-27 Sandoz Ag Process for the production of a pharmaceutical formulation for the nasal administration of serotonin antagonists
IL91856A0 (en) * 1988-10-11 1990-06-10 Schiapparelli Salute Spa Pharmaceutical compositions comprising calcitonin for intranasal administration and a spray unit for the administration of the same
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition

Also Published As

Publication number Publication date
GB8302374D0 (en) 1983-03-02
GB2114001A (en) 1983-08-17
GB2114001B (en) 1986-06-18

Similar Documents

Publication Publication Date Title
GB2117703B (en) Improvements in or relating to fire-barriers
GB8326565D0 (en) Pharmaceutical compositions
GB8327612D0 (en) Pharmaceutical compositions
GB8318564D0 (en) Pharmaceutical dermal compositions
IL70075A0 (en) Improvements in or relating to 3-aryl-5-pyrazole derivatives
ZA834074B (en) Pharmaceutical composition
EP0093551A3 (en) Pharmaceutical composition
GB2118176B (en) Pharmaceutical compositions
GB2117766B (en) Pharmaceutical compositions
PT77323A (en) Pharmaceutical compositions
GB8429749D0 (en) Pharmaceutical compositions
CY1490A (en) Improvements in or relating to nasal pharmaceutical compositions
GB8313814D0 (en) Pharmaceutical compositions
GB8329700D0 (en) Anti-haemophilic pharmaceutical composition
DE3377696D1 (en) Pharmaceutical compositions
GB8328896D0 (en) Pharmaceutical composition
GB2134577B (en) Improvements in or relating to roadsigns
GB2118587B (en) Improvements in or relating to structures
HK59989A (en) Improvements in or relating to nasal pharmaceutical compositions
GB8305028D0 (en) Pharmaceutical compositions
GB8332653D0 (en) Pharmaceutical composition
GB8314736D0 (en) Pharmaceutical compositions
GB8330810D0 (en) Pharmaceutical compositions
GB8331068D0 (en) Pharmaceutical compositions
IL68500A0 (en) Improvement in or relating to naphthalenamine derivatives